LIKE THIS PART:
The three-year agreement takes effect from 1 April 2018 and will give Admedus direct access to promote the flagship ADAPT® tissue products, CardioCel® and VascuCel®, to more than 1500 hospitals who are members of the GPO’s purchasing network which has an estimated purchasing power of $US35B.
Ann: Admedus contracts with US Group Purchasing Organisation, page-12
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.20 |
Change
0.060(0.46%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $13.33 | $13.91 | $13.20 | $293.6K | 21.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 945 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.30 | 83 | 1 |
View Market Depth
| Last trade - 14.45pm 13/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |